Stryker (SYK) Cash & Equivalents Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.16% |
| Dec 31, 2025 | 6.39% |
| Sep 30, 2025 | -14.40% |
| Jun 30, 2025 | -18.34% |
| Mar 31, 2025 | -10.16% |
| Dec 31, 2024 | -3.38% |
| Sep 30, 2024 | 14.60% |
| Jun 30, 2024 | 1.33% |
| Mar 31, 2024 | 6.84% |
| Dec 31, 2023 | -3.85% |
| Sep 30, 2023 | -0.61% |
| Jun 30, 2023 | -3.11% |
| Mar 31, 2023 | -5.17% |
| Dec 31, 2022 | -6.22% |
| Sep 30, 2022 | -11.34% |
| Jun 30, 2022 | -22.14% |
| Mar 31, 2022 | -14.62% |
| Dec 31, 2021 | -2.35% |
| Sep 30, 2021 | -2.79% |
| Jun 30, 2021 | -8.48% |
| Mar 31, 2021 | -20.34% |
| Dec 31, 2020 | -2.73% |
| Sep 30, 2020 | 17.50% |
| Jun 30, 2020 | 12.52% |
| Mar 31, 2020 | 18.82% |
| Dec 31, 2019 | 19.30% |
| Sep 30, 2019 | 7.51% |
| Jun 30, 2019 | 5.87% |
| Mar 31, 2019 | 3.92% |
| Dec 31, 2018 | 21.98% |
| Sep 30, 2018 | 11.56% |
| Jun 30, 2018 | 11.07% |
| Mar 31, 2018 | 2.64% |
| Dec 31, 2017 | 12.75% |
| Sep 30, 2017 | 12.74% |
| Jun 30, 2017 | 21.24% |
| Mar 31, 2017 | 36.02% |
| Dec 31, 2016 | 29.66% |
| Sep 30, 2016 | 29.53% |
| Jun 30, 2016 | 47.66% |
| Mar 31, 2016 | 56.84% |
| Dec 31, 2015 | 13.96% |
| Sep 30, 2015 | 27.86% |
| Jun 30, 2015 | 35.80% |
| Mar 31, 2015 | 6.84% |
| Dec 31, 2014 | 22.19% |
| Sep 30, 2014 | 7.14% |
| Jun 30, 2014 | 14.63% |